Joerg Ahlgrimm

Chief Executive Officer

Professional Overview
Joerg Ahlgrimm is an experienced pharmaceutical and biotechnology executive with a proven track record of driving operational excellence and strategic growth. As the Chief Executive Officer of SK pharmteco and Chairman of the Board at Yposkesi, an SK pharmteco company, he leverages his deep industry expertise to oversee the advancement of innovative therapies and the expansion of global manufacturing capabilities.

Experience Summary

Current Role
As CEO of SK pharmteco, Joerg is responsible for setting the strategic direction and overseeing the day-to-day operations of this leading contract development and manufacturing organization (CDMO) in the pharmaceutical and biotech industries. He also serves as the Chairman of the Board at Yposkesi, an SK pharmteco company, where he provides strategic guidance and leadership to accelerate the development and production of advanced therapies.

Prior to his current roles, Joerg served as the President and CEO of the Center for Breakthrough Medicines, a pioneering cell and gene therapy CDMO. In this position, he led the organization's growth and establishment as a premier destination for innovative therapy development.

Career Progression
Joerg's extensive career in the pharmaceutical and biotech industries spans over two decades. He has held senior leadership positions at renowned companies such as Lonza, Baxalta, and Baxter BioScience, where he excelled in driving global operations, supply chain management, and manufacturing optimization.

Joerg's deep expertise in supply chain, production planning, and operations management has enabled him to drive significant improvements in efficiency, quality, and cost-effectiveness for the organizations he has served. His ability to navigate complex regulatory landscapes and foster collaborative partnerships has contributed to the successful development and commercialization of numerous pharmaceutical and biopharmaceutical products.

Academic Background
Joerg holds a degree in Chemical Engineering from the Technical University of Braunschweig in Germany.

Areas of Expertise

• Pharmaceutical and biotech operations

• Global supply chain management

• Manufacturing optimization and efficiency

• Regulatory compliance and risk management

• Strategic leadership and business development

• Mergers, acquisitions, and strategic partnerships

Professional Impact
Under Joerg's leadership, the Center for Breakthrough Medicines experienced significant growth and became a premier CDMO in the cell and gene therapy space. He spearheaded the development of state-of-the-art manufacturing facilities and the implementation of cutting-edge technologies to support the advancement of innovative therapies.

As the CEO of SK pharmteco and Chairman of the Board at Yposkesi, Joerg continues to drive the expansion of global manufacturing capabilities and the delivery of high-quality services to the pharmaceutical and biotech industries.

Conclusion
Joerg Ahlgrimm's extensive experience and strategic vision make him a valuable asset in the pharmaceutical and biotech industries. In his current roles, he is poised to further enhance the capabilities and reach of SK pharmteco and Yposkesi, contributing to the development and production of transformative therapies that improve patient outcomes worldwide.